Home/Filings/4/0001209191-22-056439
4//SEC Filing

Dadoo Rajeev 4

Accession 0001209191-22-056439

CIK 0001671858other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 6:00 PM ET

Size

6.5 KB

Accession

0001209191-22-056439

Insider Transaction Report

Form 4
Period: 2022-11-08
Dadoo Rajeev
Director
Transactions
  • Award

    Common Stock

    2022-11-08+3,009,6773,009,677 total(indirect: See Note 2)
Footnotes (2)
  • [F1]Received in exchange for 2,546,473 shares of common stock of ARS Pharmaceuticals, Inc. ("ARS") pursuant to an Agreement and Plan of Merger and Reorganization by and among ARS, the Issuer and Sabre Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), as amended (the "Merger Agreement"). Under the terms of the Merger Agreement, on November 8, 2022, Merger Sub merged with and into ARS (the "Merger"), with ARS surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of ARS common stock was converted into the right to receive 1.1819 shares of the Issuer common stock. Subsequent to the Merger, the name of the Issuer was changed from Silverback Therapeutics, Inc. to ARS Pharmaceuticals, Inc.
  • [F2]The securities are directly held by SR One Capital Fund II Aggregator, LP ("SR One Fund II Aggregator"). SR One Capital Partners II, LP ("SR One Partners II") serves as the general partner of SR One Fund II Aggregator and SR One Capital Management, LLC serves as the general partner of SR One Partners II. The Reporting Person is the managing partner of SR One Capital Management, LP, an entity affiliated with SR One Fund II Aggregator, and a limited partner of SR One Partners II. The Reporting Person disclaims beneficial ownership of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.

Issuer

ARS Pharmaceuticals, Inc.

CIK 0001671858

Entity typeother

Related Parties

1
  • filerCIK 0001951685

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 6:00 PM ET
Size
6.5 KB